© 2024 Stocks Today
Alcon's Phase 3 trials of their innovative treatment, AR-15512, for dry eye disease (DED), have yielded highly promising outcomes. The...
On January 10, 2024, James Cordwell, an analyst at Redburn Atlantic, made a noteworthy decision regarding Apple (NASDAQ:AAPL). Cordwell downgraded...
On January 10, 2024, Barclays analyst David Anderson made a significant move in his evaluation of Helmerich & Payne (NYSE:HP)....
During the JPMorgan Healthcare conference on January 10, 2024, Lars Fruergaard Jorgensen, the CEO of Novo Nordisk, expressed his positive...
On January 10, 2024, Solo Brands (NYSE:DTC) received a downgrade from Jefferies analyst Randal Konik, shifting its status from Buy...
On January 10, 2024, Noah Poponak, an analyst at Goldman Sachs, made a noteworthy update regarding Hexcel (NYSE:HXL). Poponak decided...
On January 10, 2024, esteemed analyst Quinn Bolton, known for his impressive track record, reiterated his positive stance on SMART...
As we step into the new year of 2024, James Ricchiuti, the esteemed Needham analyst, continues to uphold a resolute...
On January 10, 2024, AZZ Inc. (NYSE: AZZ) announced impressive third-quarter results for FY24, resulting in a surge in its...
Tilray, a leading player in the pharmaceutical and cannabis industry, has recently taken a significant step towards expanding its market...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.